ENSG00000223804 and cancer: Thanks to the extensive understanding about the molecular mechanisms (mis)regulating rRNA transcription in cancer, compounds targeting the PolI transcriptional machinery are currently in clinical trials to treat different types of cancer [132,133,134,135].